Drospirenone + Ethinylestradiol
Lesine is a contraceptive pill and is used to prevent pregnancy.
Each coated tablet contains a small amount of two different female hormones, namely
drospirenone and ethinylestradiol.
Contraceptive pills that contain two hormones are called "combined" pills.
Before starting to take Lesine, you should read the information about
blood clots (thrombosis) in section 2. It is especially important to read about the symptoms
of blood clots (see section 2 "Blood clots").
Before you can start taking Lesine, your doctor will ask you a few questions about your health and about
the health of your close relatives. Your doctor will also measure your blood pressure and, in individual
cases, may also perform some other tests.
This leaflet describes several situations in which you should stop taking Lesine, or in which the effectiveness of Lesine may be reduced. In such situations, you should either not have sexual intercourse or use additional non-hormonal contraceptive methods, such as
condoms or other mechanical methods. You should not use the calendar method or the temperature measurement method. These methods may be unreliable because Lesine modifies the monthly
changes in body temperature and cervical mucus.
You should not take Lesine if you have any of the conditions listed below. If you have any of the conditions listed below, you should inform your doctor. Your doctor will discuss with you which other contraceptive method will be more suitable for you.
Additional information for special populations
Children and adolescents
Lesine is not intended for use in girls who have not yet started their menstrual cycles.
Older women
Lesine is not intended for use after menopause.
Women with liver disease
You should not take Lesine if you have liver disease. See also sections "When not to take Lesine" and "Warnings and precautions".
Women with kidney disease
You should not take Lesine if you have kidney failure or acute kidney failure. See also sections "When not to take Lesine" and "Warnings and precautions".
You should discuss this with your doctor or pharmacist before starting to take Lesine.
When should you contact your doctor?
To find out more about the symptoms of these serious side effects, see "How to recognize a blood clot".
Before taking Lesine, you should consult your doctor. In some situations, you should be extra careful when taking Lesine or any other combined hormonal contraceptive, and you may need to have regular check-ups with your doctor. If these symptoms occur or worsen while taking Lesine, you should also tell your doctor:
if you have (or have had) chloasma (skin discoloration, especially on the face and neck, also known as melasma). If so, you should avoid direct exposure to sunlight or ultraviolet radiation
Taking combined hormonal contraceptives, such as Lesine, is associated with an increased risk of blood clotscompared to not taking them. In rare cases, a blood clot can block a blood vessel and cause serious complications.
Blood clots can occur
Not everyone who has a blood clot will recover fully. In rare cases, the effects of a blood clot can be long-lasting or, very rarely, fatal.
You should contact your doctor immediately if you notice any of the following symptoms.
What disease is likely to occur in the patient
If you are unsure, you should contact your doctor, as some of these symptoms, such as coughing or shortness of breath, can be mistaken for less serious conditions, such as a respiratory infection (e.g., a cold).
do lekarza, ponieważ niektóre z tych objawów, takie jak kaszel lub duszność mogą zostać pomylone z łagodniejszymi stanami, takimi jak zakażenie układu oddechowego (np. przeziębienie). | |
Objawy występują najczęściej w jednym oku:
| Zakrzepica żył siatkówki (zakrzep krwi w oku) |
| Zawał serca |
| Udar mózgu |
| Zakrzepy krwi blokujące inne naczynia krwionośne |
The risk of forming a blood clot in a vein is highest during the first year of taking combined hormonal contraceptives for the first time. The risk may also be higher when resuming combined hormonal contraceptives (the same or a different medicine) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always higher than when not taking combined hormonal contraceptives.
If you stop taking Lesine, the risk of blood clots returns to normal within a few weeks.
The risk depends on the natural risk of venous thromboembolism and the type of combined hormonal contraceptive used.
The overall risk of blood clots in the legs or lungs associated with taking Lesine is small.
Risk of blood clots in a year | |
Women who do not take combined hormonal pills/patches/rings and are not pregnant | About 2 in 10,000 women |
Women taking combined hormonal contraceptive pills containing levonorgestrel, norethisterone, or norgestimate | About 5-7 in 10,000 women |
Women taking Lesine | About 9-12 in 10,000 women |
The risk of blood clots associated with taking Lesine is small, but some factors can increase this risk. The risk is higher:
The risk of blood clots increases with the number of risk factors present in the patient.
Long-haul flights (>4 hours) may temporarily increase the risk of blood clots, especially if you have another risk factor.
It is essential to tell your doctor if any of these risk factors apply to you, even if you are not sure. Your doctor may decide to stop you from taking Lesine.
You should inform your doctor if any of these conditions change while taking Lesine, e.g., if someone in your close family is diagnosed with a blood clot without a known cause or if you gain significant weight.
Similarly to blood clots in veins, blood clots in arteries can cause serious consequences, such as a heart attack or stroke.
It is essential to note that the risk of a heart attack or stroke associated with taking Lesine is very small, but it may increase:
If you have more than one of these conditions or if any of them are severe, the risk of blood clots may be even higher.
You should inform your doctor if any of these conditions change while taking Lesine, e.g., if you start smoking, if someone in your close family is diagnosed with a blood clot without a known cause, or if you gain significant weight.
Women taking combined contraceptives have a slightly higher risk of breast cancer, but it is not known if this is caused by the medicine. For example, it may be that more breast cancers are detected in women taking combined contraceptives because they are more likely to have regular medical check-ups.
The risk of breast cancer gradually decreases after stopping combined hormonal contraceptives.
Women taking combined contraceptives have also been reported to have an increased risk of benign liver tumors and, in rare cases, liver cancer. If you experience severe abdominal pain, you should contact your doctor.
During the first few months of taking Lesine, you may experience irregular bleeding (bleeding outside of the weekly break). If such bleeding continues for more than a few months or starts after a few months, your doctor should investigate the cause.
If you have taken all the tablets as directed, have not vomited, or had severe diarrhea, and have not taken any other medicines, it is very unlikely that you are pregnant.
If the expected bleeding does not occur for two consecutive weeks, it may mean that you are pregnant.
You should contact your doctor immediately. Do not start the next blister pack until you are sure you are not pregnant.
Some women taking hormonal contraceptives, including Lesine, have reported depression or mood swings. Depression can be severe and, in some cases, lead to suicidal thoughts.
If you experience mood changes or symptoms of depression, you should contact your doctor as soon as possible for further medical advice.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should also tell any other doctor or dentist prescribing another medicine (or pharmacist) that you are taking Lesine. They may tell you if you need to use additional contraceptive methods (e.g., condoms) and for how long or if you need to adjust the dosage of other medicines.
Some medicines may affect the levels of Lesine in your blood and may cause it to be lesseffective in preventing pregnancyor may cause irregular bleeding. These include:
Lesine may affect the action of other medicines, such as:
medicines containing cyclosporin
antiepileptic medicines containing lamotrigine (may increase the risk of seizures)
theophylline (used for breathing problems),
tizanidine (used to treat muscle pain and/or muscle spasms).
Before taking any medicine, you should consult your doctor or pharmacist.
You should not take Lesine if you have hepatitis C and are taking medicines containing ombitasvir/paritaprevir/ritonavir, dasabuvir, glecaprevir/pibrentasvir, or sofosbuvir/velpatasvir/voxilaprevir, as this may increase liver function test results in the blood (increase in liver enzyme ALT).
Your doctor will prescribe a different contraceptive method before starting treatment with these medicines.
Lesine can be taken again about 2 weeks after finishing this treatment. See section "When not to take Lesine".
Lesine can be taken with or without food, as needed, with a small amount of water.
If you need to have a blood test, you should tell your doctor or laboratory staff that you are taking a contraceptive, as oral contraceptives may affect the results of some tests.
Pregnancy
Lesine should not be taken during pregnancy. If you become pregnant while taking Lesine, you should stop taking it immediately and contact your doctor.
If you want to become pregnant, you can stop taking Lesine at any time (see also "Stopping Lesine").
Before taking any medicine, you should consult your doctor or pharmacist.
Breastfeeding
Lesine is not usually recommended during breastfeeding. If you want to take a contraceptive while breastfeeding, you should consult your doctor.
Before taking any medicine, you should consult your doctor or pharmacist.
Lesine contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which means it is essentially "sodium-free".
There is no information to suggest that taking Lesine affects the ability to drive or use machines.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine should always be taken exactly as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
You should take one Lesine tablet every day, as needed, with a small amount of water.
You can take the tablets with or without food, but you should take them at the same time every day.
The blister pack contains 21 coated tablets. The day of the week is printed next to each tablet. If, for example, you start taking the tablets on a Wednesday, you should take the tablet with "Wed" printed next to it. You should move in the direction of the arrow on the blister pack until all 21 tablets have been taken.
Then, you should not take any tablets for 7 days. During these 7 days (also known as the "week off"), you should experience bleeding. This is called "withdrawal bleeding", which usually starts on the 2nd or 3rd day of the week off.
On the 8th day after taking the last Lesine tablet (i.e., after the 7-day break), you should start a new blister pack, regardless of whether the bleeding has stopped or not. This means that you should start each new blister pack on the same day of the week, and the withdrawal bleeding should occur on the same days every month.
If you take Lesine in this way, you are protected from pregnancy during the 7 days when you are not taking tablets.
If you have had sex after giving birth and before (re)starting Lesine, you should first make sure you are not pregnant or wait until your next menstrual period.
If you are unsure when to start taking Lesine, you should consult your doctor.
There are no reports of serious, harmful effects from taking too many Lesine tablets at once.
If you take several tablets at once, you may experience nausea and vomiting or vaginal bleeding. This type of bleeding can occur even in girls who have not yet started their menstrual cycles, but have taken the medicine by mistake.
If you take too many Lesine tablets or if a child swallows them, you should consult your doctor or pharmacist.
The risk of reduced protection from pregnancy is highest if you forget to take a tablet at the beginning or end of the blister pack. Therefore, you should follow the instructions below (see also the diagram below):
Instead of the tablet-free week, you can start taking tablets from the next blister pack immediately.
It is likely that you will experience bleeding at the end of the second blister pack, but you may also experience spotting or breakthrough bleeding while taking tablets from the second blister pack.
Forgot to take more
than 1 tablet from this
blister pack
Should consult a doctor
yes
in week 1.
Did you have sex during the week
before forgetting the tablet?
Only 1 tablet forgotten
(taken more than 12 hours
late)
If you vomit within 3 to 4 hours of taking a tablet or have severe diarrhea, there is a risk that the active ingredients from the tablet may not have been fully absorbed into your bloodstream.
The situation is similar to forgetting a tablet. After vomiting or diarrhea, you should take another tablet from the spare blister pack as soon as possible. If possible, you should take it within
12 hoursof the normal time for taking the tablet. If this is not possible or more than 12 hours have passed, you should follow the instructions given in the section "If you forget to take Lesine".
Although it is not recommended, you can delay your period by going straight to the next Lesine blister pack, skipping the tablet-free week, and finishing it. You may experience spotting or breakthrough bleeding while taking tablets from the second blister pack.
After the usual 7-day tablet-free period, you should starttaking tablets from the next blister pack.
You can ask your doctor for advice before making a decision to delay your period.
If you take the tablets as directed, your period will start during the tablet-free week. If you want to change this day, you can do so by shortening (but never lengthening - maximum 7 days!) the tablet-free period. For example, if your tablet-free period starts on a Friday and you want to change the day to a Tuesday (3 days earlier), you should start the next blister pack 3 days earlier than usual. If the tablet-free period is very short (e.g., 3 days or less), you may experience bleeding during those days. As a result, you may experience spotting or breakthrough bleeding.
If you are unsure what to do, you should consult your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If any side effects occur, especially severe and persistent ones, or changes in health that the patient considers to be related to the use of Lesine, the patient should consult her doctor. All women using combined hormonal contraceptives have an increased risk of developing blood clots in the veins (venous thromboembolism) or blood clots in the arteries (arterial thromboembolism). For detailed information on the different risk factors associated with the use of combined hormonal contraceptives, the patient should refer to section 2 "Important information before taking Lesine". Severe side effects The patient should immediately contact her doctor if she experiences any of the following symptoms of angioedema: swelling of the face, tongue, and/or throat, and/or difficulty swallowing, or hives that may cause difficulty breathing (see also the section "Warnings and precautions"). The following side effects have been associated with the use of Lesine. Common side effects (may occur in up to 1 in 10 people)
Uncommon side effects (may occur in up to 1 in 100 people)
Rare side effects (may occur in up to 1 in 1,000 people)
The risk of developing blood clots may be higher if the patient has any other risk factors (see section 2 for further information on risk factors for blood clots and symptoms of blood clots).
If any side effects occur, including any side effects not listed in the leaflet, the patient should tell her doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, PL-02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children. This medicine does not require any special precautions for storage.
Do not use this medicine after the expiry date stated on the blister and packaging after the words "Expiry date" or "EXP". The expiry date refers to the last day of the given month. Medicines should not be disposed of via wastewater or household waste. The patient should ask her pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of Lesine are ethinylestradiol and drospirenone. Each tablet contains 0.03 mg of ethinylestradiol and 3 mg of drospirenone. The other ingredients are: Tablet core: lactose monohydrate, corn starch, pregelatinized starch, maize starch, crospovidone, povidone K30, polysorbate 80, magnesium stearate. Tablet coating: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, yellow iron oxide (E172).
Yellow, round, film-coated tablets.
Not all pack sizes may be marketed.
Theramex Ireland Limited, 3rd Floor, Kilmore House, Park Lane, Spencer Dock, Dublin 1, D01 YE64, Ireland
Laboratorios León Farma S.A., C/ La Vallina s/n, Pol. Ind. Navatejera, 24193 Villaquilambre – Leon, Spain, Merckle GmbH, Ludwig-Merckle-Straße 3, 89143 Blaubeuren, Germany
Date of revision of the leaflet:May 2025
Country name | Medicinal product name |
Norway: | Dretine 0,03 mg/3 mg tablets, film-coated |
Austria: | Dretine 0,03 mg/3 mg 21 film-coated tablets |
Czech Republic: | Softine 0,03 mg/3 mg film-coated tablets |
Spain: | Dretine 0.03 mg/3 mg film-coated tablets |
Hungary: | Corenelle 0.03 mg/3 mg film-coated tablets |
Ireland: | Dretine 0.03 mg/3 mg film-coated tablets |
Poland: | Lesine |
Slovakia: | Softine 0,03mg/3mg film-coated tablets |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.